The estimated Net Worth of Elizabeth H Davila is at least $438 Thousand dollars as of 3 December 2013. Ms. Davila owns over 8,000 units of Accuray Inc stock worth over $151,960 and over the last 17 years she sold ARAY stock worth over $61,920. In addition, she makes $223,749 as Independent Director at Accuray Inc.
Elizabeth has made over 2 trades of the Accuray Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently she sold 8,000 units of ARAY stock worth $61,920 on 3 December 2013.
The largest trade she's ever made was selling 8,000 units of Accuray Inc stock on 3 December 2013 worth over $61,920. On average, Elizabeth trades about 321 units every 75 days since 2008. As of 3 December 2013 she still owns at least 77,137 units of Accuray Inc stock.
You can see the complete history of Ms. Davila stock trades at the bottom of the page.
Elizabeth H. Davila is an Independent Director of the Company. She also served as Vice Chairperson of our Board from September 2008 through November 2017. Ms. Dávila was the former Chairman and Chief Executive Officer of VISX, Incorporated (“VISX”), a manufacturer of laser vision correction systems, which was acquired by Advanced Medical Optics in May 2005. Prior to becoming Chairman and Chief Executive Officer of VISX in 2001, she served as President and Chief Operating Officer of VISX from 1999 to 2001 and as Executive Vice President and Chief Operating Officer from 1995 to 1999. Ms. Dávila currently serves as a member of the board of directors of Afaxys, Inc., a private company that supplies family planning providers with pharmaceuticals and supplies and in the past five years has served as a member of the board of directors of NuGEN Technologies, Inc., a private company that develops and commercializes rapid, high-sensitivity and high-throughput amplification and labeling systems for genomic analysis, which was acquired by the Tecan Group in September 2018. Ms. Dávila holds a B.S. in Chemistry from St. Mary’s College in Notre Dame, Indiana, a M.S. in Chemistry from the University of Notre Dame and a M.B.A. from Stanford University.
As the Independent Director of Accuray Inc, the total compensation of Elizabeth Davila at Accuray Inc is $223,749. There are 10 executives at Accuray Inc getting paid more, with Ali Pervaiz having the highest compensation of $5,183,662.
Elizabeth Davila is 75, she's been the Independent Director of Accuray Inc since 2017. There are no older and 15 younger executives at Accuray Inc.
Elizabeth's mailing address filed with the SEC is 1310, Chesapeake Terrace, Sunnyvale, Santa Clara County, California, 94089, United States.
Over the last 18 years, insiders at Accuray Inc have traded over $37,863,458 worth of Accuray Inc stock and bought 806,995 units worth $5,047,672 . The most active insiders traders include International Investment Ho..., Robert S Weiss, and Euan Thomson. On average, Accuray Inc executives and independent directors trade stock every 24 days with the average trade being worth of $62,792. The most recent stock trade was executed by Ali Pervaiz on 4 September 2024, trading 8,404 units of ARAY stock currently worth $17,312.
accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.
Accuray Inc executives and other stock owners filed with the SEC include: